美国FDA药品溶出方法数据库

药品通用名称	剂型	USP溶出装置	速度	溶出介质	介质体积	建议取样时间（分钟）	更新日期
Alogliptin Benzoate/ Metformin HCl	Tablet	II (Paddle)	50	0.01 N HCl	900	5, 10, 15, 20 and 30	2015/11/19
Alosetron HCl	Tablet			Refer to FDA's Dissolution Guidance, 2018			2020/07/02
Alpelisib	Tablet	II (Paddle)	75	Acetate Buffer, pH 4.5 w/0.6% CTAB	900	10, 15, 20, 30 and 45	2025/02/24
Alprazolam	Tablet (Orally Disintegrating)	II (Paddle)	50	70 mM Potassium Phosphate Buffer, pH 6.0	500	2, 5, 10, 15 and 20	2008/10/06
Alprazolam	Tablet			Refer to FDA's Dissolution Guidance, 2018			2020/07/02
Alprazolam	Tablet (Extended Release)	I (Basket)	100	1% Phosphate Buffer, pH 6.0	500	1, 4, 8, 12 and 16 hours	2007/02/08
Altretamine	Capsule			Refer to USP			2010/01/29
Aluminum Hydroxide/Magnesium Trisilicate	Tablet (Chewable)			Develop a dissolution method			2022/05/12
Alvimopan	Capsule	II (Paddle	50	0.1 N HCl	900	5, 10, 15, 20, 30 and 45	2010/10/21
Amantadine HCl	Capsule			Refer to FDA's Dissolution Guidance, 2018			2020/07/02
Amantadine HCl	Tablet			Refer to FDA's Dissolution Guidance, 2018			2020/07/02
Amantadine Hydrochloride	Capsule, Extended Release			Develop a dissolution method			2025/09/08
Ambrisentan	Tablet	II (Paddle)	75	0.05 M Acetate Buffer, pH 5.0	900	5, 10, 15, 30, and 45	2009/05/20
Amifampridine	Tablet			Refer to FDA's Dissolution Guidance, 2018			2021/08/19
Amifampridine Phosphate	Tablet			Refer to FDA's Dissolution Guidance, 2018			2021/08/19
Amiloride HCl	Tablet			Refer to FDA's Dissolution Guidance, 2018			2020/07/02
Amiloride HCl/Hydrochlorothiazide	Tablet			Refer to USP			2012/06/07
Aminocaproic Acid	Tablet			Refer to FDA's Dissolution Guidance, 2018			2024/01/03
Aminosalicylic	Granule (Delayed Release)	II (Paddle)	100	Acid Stage: 0.1 N HCl; Buffer Stage 2: pH 7.5 Phosphate Buffer	1000	Acid Stage: 2 hours; Buffer Stage: 1, 2, 3 and 4 hours	2008/07/14
Amiodarone HCl (Test 1)	Tablet			Develop a dissolution method			2023/09/15